The FSSAI intensified its scrutiny of Dabur India, mandating an audit of 27 product lines for misleading health claims. The regulator has required scientific evidence for these claims while urging compliance to ensure consumer safety.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.